Subcutaneously Administered Aldesleukin ( Interleukin-2; IL-2 ) Therapy in HIV-Infected Patients
Clinical trial NCT00000821 · COMPLETED
Trial details
- NCT number
- NCT00000821
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.